APP下载

不同剂量131I对分化型甲状腺癌患者血清中TH水平及生活质量的影响

2016-11-21王钇力许明君杨静衷敬华肖丽霞钟

上海医药 2016年21期
关键词:剂量血清疗效

王钇力+许明君+杨静+衷敬华+肖丽霞+钟明超

摘 要 目的: 探讨不同剂量131I对分化型甲状腺癌患者血清中甲状腺激素水平及生活质量的影响。方法:回顾性分析2012年1月—2015年3月我院收治的85例分化型甲状腺癌患者,所有患者均进行甲状腺癌切除手术,术后给予131I治疗,根据剂量不同分为3组,A组为1次应用131I治疗的患者,共27例,累计剂量为2.96~3.70 GBq,B组为2次应用131I治疗的患者,共23例,累计剂量为8.14~10.36 GBq,C组3次应用131I治疗的患者,共20例,累计剂量为12.95~17.02 GBq,比较3组患者治疗前后的临床疗效,生活质量评分,另15例同期未接受131I治疗的患者作为对照。结果: 131I治疗组的有效率均显著高于对照组,B、C组有效率最高,A组次之(P<0.05);3组患者治疗后躯体功能、角色功能、认知功能、情绪功能以及社会功能等方面的评分均显著高于治疗前, B组治疗后的生存质量评分最高,C组次之,A组最低,组间差异有统计学意义。结论:131I治疗分化型甲状腺癌疗效显著,可提高患者的生活质量,其中以B组的治疗方案效果最佳。

关键词 131I 分化型甲状腺癌 甲状腺激素

中图分类号:R736.1; R730.55 文献标识码:B 文章编号:1006-1533(2016)21-0036-04

Effects of the different doses of 131iodine on the serum thyroid hormone level and quality of life in the treatment of patients with differentiated thyroid cancer

WANG Yili1 XU Mingjun1 YANG Jing1 ZHONG Jinghua1 XIAO Lixia2 ZHONG Mingcao3(1. Department of Oncology, the First Hospital affiliated to Gannan Medical College, Ganzhou 341000, China;2. Department of Endocrinology, the First Hospital affiliated to Gannan Medical College, Ganzhou 341000, China;3. Isotope Laboratory, the First Hospital affiliated to Gannan Medical College, Ganzhou 341000, China)

ABSTRACT Objective: To discuss the different doses of 131I on serum thyroid hormone (TH) level and quality of life in the treatment of patients with differentiated thyroid cancer. Methods: Eighty-five patients with differentiated thyroid cancer were selected and underwent thyroid cancer resection surgery, and were postoperatively treated with 131I. They were divided into group A (27 cases, treated with a cumulative dose of 2.96 ~ 3.70 GBq once), B (23 cases, treated with a cumulative dose of 8.14 ~ 10.36 GBq twice) and C (20 cases, treated with a cumulative dose of 12.95 ~ 17.02 GBq for three times). Their clinical efficacy and the scores of the quality of life were compared before and after treatment. Meanwhile, another fifteen patients who did not received 131I treatment at the same time were selected as a control group. Results: The total effective rates were significantly higher in group A, B and C than in the control group with group B and C the highest (P<0.05). The scores of physical, role, cognitive, emotional and social functions were significantly higher after treatment than before and the scores of life quality were the highest in group B following by group C and A (P<0.05). Conclusion: The treatment of differentiated thyroid cancer with 131I can significantly improve the quality of life of patients and possesses a clearly curative effect, and the therapeutic regimen in group B is the best.

KEY WORDS 131I; differentiated thyroid cancer; thyroid hormone

状腺癌总量的79%。分化型甲状腺癌女性患者的发病率要远高于男性[1]。目前,最佳的治疗方法是手术切除肿瘤原发灶后,使用131I对残留甲状腺癌细胞和转移灶进行清除,再服用甲状腺激素(TH)替代治疗,从而降低癌症的复发率,延长患者的生命[2]。本研究通过比较不同剂量131I治疗分化型甲状腺癌对患者血清中TH水平及生活质量的影响,旨在为分化型甲状腺癌131I治疗剂量的选择、临床疗效及对生活质量的提高提供依据,现报道如下。

1 资料与方法

1.1 一般资料

回顾性分析2012年1月—2015年3月的我院收治的85例分化型甲状腺癌患者,纳入标准[3]:患者在进行131I治疗前均进行手术切除治疗。排除标准:①患者具有唾液腺疾病病史;②患者曾经进行头颈部放疗。……

登录APP查看全文

猜你喜欢

剂量血清疗效
结合剂量,谈辐射
·更正·
血清免疫球蛋白测定的临床意义
Meigs综合征伴血清CA-125水平升高1例
90Sr-90Y敷贴治疗的EBT3胶片剂量验证方法
慢性鼻-鼻窦炎患者血清IgE、IL-5及HMGB1的表达及其临床意义
止眩汤改良方治疗痰瘀阻窍型眩晕的临床疗效观察
冷喷联合湿敷甘芩液治疗日晒疮的短期疗效观察
中西医结合治疗慢性盆腔炎的疗效观察
高剂量型流感疫苗IIV3-HD对老年人防护作用优于标准剂量型